- Report
- July 2023
- 332 Pages
United States
From €7091EUR$7,995USD£6,151GBP
- Report
- March 2018
- 159 Pages
Global
From €6652EUR$7,500USD£5,770GBP
- Report
- August 2024
- 272 Pages
China
From €3548EUR$4,000USD£3,077GBP
- Report
- August 2024
- 88 Pages
China
From €1596EUR$1,800USD£1,385GBP
- Report
- May 2022
- 47 Pages
Global
From €1774EUR$2,000USD£1,539GBP
- Report
- January 2023
- 114 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- July 2024
- 155 Pages
Global
From €3204EUR$3,613USD£2,779GBP
€3770EUR$4,250USD£3,270GBP
- Report
- October 2023
- 146 Pages
Global
From €3129EUR$3,528USD£2,714GBP
€3681EUR$4,150USD£3,193GBP
- Report
- October 2024
- 80 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- July 2023
- 101 Pages
Global
From €3500EUR$4,227USD£3,142GBP
- Report
- April 2024
- 132 Pages
Global
From €843EUR$950USD£731GBP
- Book
- July 2021
- 816 Pages
- Book
- July 2020
- 416 Pages
The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more
